Literature DB >> 15367598

Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.

Simona Ozden1, Madeleine Cochet, Jacqueline Mikol, Antonio Teixeira, Antoine Gessain, Claudine Pique.   

Abstract

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) infection can lead to the development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), concomitantly with or without other inflammatory disorders such as myositis. These pathologies are considered immune-mediated diseases, and it is assumed that migration within tissues of both HTLV-1-infected CD4(+) T cells and anti-HTLV-1 cytotoxic T cells represents a pivotal event. However, although HTLV-1-infected T cells were found in inflamed lesions, the antigenic specificity of coinfiltrated CD8(+) T cells remains to be determined. In this study, we performed both ex vivo and in situ analyses using muscle biopsies obtained from an HTLV-1-infected patient with HAM/TSP and sporadic inclusion body myositis. We found that both HTLV-1-infected CD4(+) T cells and CD8(+) T cells directed to the dominant Tax antigen can be amplified from muscle cell cultures. Moreover, we were able to detect in two successive muscle biopsies both tax mRNA-positive mononuclear cells and T cells recognized by the Tax11-19/HLA-A*02 tetramer and positive for perforin. These findings provide the first direct demonstration that anti-Tax cytotoxic T cells are chronically recruited within inflamed tissues of an HTLV-1 infected patient, which validates the cytotoxic immune reaction model for the pathogenesis of HTLV-1-associated inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367598      PMCID: PMC516372          DOI: 10.1128/JVI.78.19.10320-10327.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4+ lymphocytes.

Authors:  I Higuchi; K Hashimoto; E Matsuoka; R Rosales; M Nakagawa; K Arimura; S Izumo; M Osame
Journal:  Acta Neuropathol       Date:  1996-10       Impact factor: 17.088

2.  In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes.

Authors:  M Saito; G P Taylor; A Saito; Y Furukawa; K Usuku; J N Weber; M Osame; C R Bangham
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France.

Authors:  A Gessain; O Gout; F Saal; M T Daniel; B Rio; G Flandrin; F Sigaux; O Lyon-Caen; J Periès; G de-Thé
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

4.  Inclusion body myositis in HIV-1 and HTLV-1 infected patients.

Authors:  E J Cupler; M Leon-Monzon; J Miller; C Semino-Mora; T L Anderson; M C Dalakas
Journal:  Brain       Date:  1996-12       Impact factor: 13.501

5.  Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.

Authors:  E Wu; D W Dickson; S Jacobson; C S Raine
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease.

Authors:  M Leon-Monzon; I Illa; M C Dalakas
Journal:  Ann Neurol       Date:  1994-10       Impact factor: 10.422

7.  Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes.

Authors:  T Moritoyo; T A Reinhart; H Moritoyo; E Sato; S Izumo; M Osame; A T Haase
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

8.  Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization.

Authors:  T J Lehky; C H Fox; S Koenig; M C Levin; N Flerlage; S Izumo; E Sato; C S Raine; M Osame; S Jacobson
Journal:  Ann Neurol       Date:  1995-02       Impact factor: 10.422

9.  Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis.

Authors:  I Higuchi; K Hashimoto; N Kashio; S Izumo; M Inose; K Izumi; R Ohkubo; M Nakagawa; K Arimura; M Osame
Journal:  Muscle Nerve       Date:  1995-08       Impact factor: 3.217

10.  Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  H Hara; M Morita; T Iwaki; T Hatae; Y Itoyama; T Kitamoto; S Akizuki; I Goto; T Watanabe
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

Review 2.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

3.  Human T-Cell Lymphotropic Virus Type 1 Transactivator Tax Exploits the XPB Subunit of TFIIH during Viral Transcription.

Authors:  Christophe Martella; Armelle Inge Tollenaere; Laetitia Waast; Benoit Lacombe; Damien Groussaud; Florence Margottin-Goguet; Bertha Cecilia Ramirez; Claudine Pique
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

4.  Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.

Authors:  Simona Ozden; Vincent Mouly; Marie-Christine Prevost; Antoine Gessain; Gillian Butler-Browne; Pierre-Emmanuel Ceccaldi
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease.

Authors:  Yoshimi Enose-Akahata; Eiji Matsuura; Yuetsu Tanaka; Unsong Oh; Steven Jacobson
Journal:  Retrovirology       Date:  2012-02-15       Impact factor: 4.602

6.  Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Eiji Matsuura; Akiko Yoshimura; Satoshi Nozuma; Itsuro Higuchi; Ryuji Kubota; Hiroshi Takashima
Journal:  BMC Neurol       Date:  2015-02-28       Impact factor: 2.474

7.  Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.

Authors:  Damien Groussaud; Mostafa Khair; Armelle I Tollenaere; Laetitia Waast; Mei-Shiue Kuo; Marianne Mangeney; Christophe Martella; Yann Fardini; Solène Coste; Mouloud Souidi; Laurence Benit; Claudine Pique; Tarik Issad
Journal:  PLoS Pathog       Date:  2017-07-24       Impact factor: 6.823

8.  Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.

Authors:  Yukie Tanaka; Tomoo Sato; Naoko Yagishita; Junji Yamauchi; Natsumi Araya; Satoko Aratani; Katsunori Takahashi; Yasuo Kunitomo; Misako Nagasaka; Yoshinobu Kanda; Kaoru Uchimaru; Tomohiro Morio; Yoshihisa Yamano
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

9.  The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Ayako Takamori; Shuichi Kinpara; Atae Utsunomiya
Journal:  Front Microbiol       Date:  2012-09-03       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.